SW1271Homo sapiens (Human)Cancer cell line

Also known as: SW 1271, SW-1271

🤖 AI SummaryBased on 5 publications

Quick Overview

SW1271 is a human epithelial cell line used in cancer research, particularly in studies related to small-cell lung carcinoma (S...

Detailed Summary

SW1271 is a human epithelial cell line derived from small-cell lung carcinoma (SCLC). It is widely used in cancer research, particularly in studies focused on the genetic and molecular mechanisms of SCLC. This cell line has been utilized in investigations involving the identification of genomic markers associated with drug sensitivity, such as the amplification of the Bcl-2 gene on chromosome 18q21.3, which correlates with sensitivity to Bcl-2 inhibitors like ABT-737. Research on SW1271 has contributed to understanding the role of Bcl-2 and NOXA in apoptosis regulation and their implications for cancer therapy. Additionally, SW1271 has been part of studies examining the clinical relevance of 18q21-23 copy number gains in SCLC, highlighting its importance in predicting response to Bcl-2 family inhibitors. The cell line's utility in drug sensitivity profiling and its role in elucidating the genetic basis of SCLC make it a valuable resource for cancer research.

Research Applications

Genomic marker identification for drug sensitivityApoptosis regulation studiesBcl-2 and NOXA gene amplification analysisSmall-cell lung carcinoma (SCLC) researchDrug sensitivity profiling

Key Characteristics

Amplification of Bcl-2 gene on 18q21.3Sensitivity to Bcl-2 inhibitors like ABT-737Expression of Bcl-2 and NOXA genes18q21-23 copy number gainsUsed in studies of SCLC tumor biology
Generated on 6/17/2025

Basic Information

Database IDCVCL_1716
SpeciesHomo sapiens (Human)
Tissue SourceLung[UBERON:UBERON_0002048]

Donor Information

Age69
Age CategoryAdult
SexMale
Racecaucasian

Disease Information

DiseaseSmall cell lung cancer
LineageLung
SubtypeSMARCA4-deficient undifferentiated tumor

DepMap Information

Source TypeATCC
Source IDACH-000890_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Cys277Phe (c.830G>T)Unspecified-Unknown
MutationSimpleSMARCA4p.Asn774Lys (c.2322C>A)Homozygous-Unknown
MutationSimpleNRASp.Gln61Arg (c.182A>G)Unspecified-PubMed=26214590

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
11
D10S1248
13,16
D12S391
18,20
D13S317
13
D16S539
11,12
D18S51
14
D19S433
14
D1S1656
15
D21S11
29,31.2
D22S1045
15
D2S1338
23
D2S441
11
D3S1358
15
D5S818
12
D7S820
9,12
D8S1179
13,16
FGA
20
Penta D
10,12
Penta E
5,12
TH01
7,8
TPOX
8
vWA
17,20
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Molecular and pathologic characterization of YAP1-expressing small cell lung cancer cell lines leads to reclassification as SMARCA4-deficient malignancies.

Burr M.L., Sutherland K.D.

Clin. Cancer Res. 30:1846-1858(2024).

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

Quantitative proteomics of the Cancer Cell Line Encyclopedia.";

Sellers W.R., Gygi S.P.

Cell 180:387-402.e16(2020).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

A resource for cell line authentication, annotation and quality control.

Neve R.M.

Nature 520:307-311(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

Integrative genomic analysis of small-cell lung carcinoma reveals correlates of sensitivity to bcl-2 antagonists and uncovers novel chromosomal gains.

Sauter G., Lesniewski R., Semizarov D.

Mol. Cancer Res. 5:331-339(2007).

Human tumor lines for cancer research.";

Fogh J.

Cancer Invest. 4:157-184(1986).

p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines.

Gerwin B.I., Harris C.C.

Cancer Res. 51:4090-4096(1991).